Outcomes of Long Bones Treated With Carbon-Fiber Nails for Oncologic Indications: International Multi-institutional Study
Authors: Lozano-Calderon Santiago A. , Rijs Zeger , Groot Oliver Q. , Su Marie W. , Werenski Joseph O. , Merchan Nelson , Yeung Caleb M. , Sodhi Alisha , Berner Emily , Oliveira Vania , Bianchi Giuseppe , Staals Eric , Lana Debora , Donati Davide , Segal Ortal , Marone Stefano , Piana Raimondo , Meo Simone De , Pellegrino Pietro , Ratto Nicola , Zoccali Carmine , Scorianz Maurizio , Tomai Cecilia , Scoccianti Guido , Campanacci Domenico Andrea , Andreani Lorenzo , Franco Silvia de , Boffano Michele , Pensado Manuel Peleteiro , Ruiz Irene Barrientos , Moreno Esperanza Holgado , Ortiz-Cruz Eduardo Jose , van de Sande Michiel 
Published: October 2023

Background:

Intramedullary nail fixation is commonly used for prophylactic stabilization of impending and fixation of complete pathological fractures of the long bones. However, metallic artifacts complicate imaging evaluation for bone healing or tumor progression and postoperative radiation planning. Carbon-fiber implants have gained popularity as an alternative, given their radiolucency and superior axial bending. This study evaluates incidences of mechanical and nonmechanical complications.

Methods:

Adult patients (age 18 years and older) treated with carbon-fiber nails for impending/complete pathological long bone fractures secondary to metastases from 2013 to 2020 were analyzed for incidences and risk factors of mechanical and nonmechanical complications. Mechanical complications included aseptic screw loosening and structural failures of host bone and carbon-fiber implants. Deep infection and tumor progression were considered nonmechanical. Other complications/adverse events were also reported.

Results:

A total of 239 patients were included; 47% were male, and 53% were female, with a median age of 68 (IQR, 59 to 75) years. Most common secondary metastases were related to breast cancer (19%), lung cancer (19%), multiple myeloma (18%), and sarcoma (13%). In total, 17 of 30 patients with metastatic sarcoma received palliative intramedullary nail fixation for impending/complete pathological fractures, and 13 of 30 received prophylactic nail stabilization of bone radiated preoperatively to manage juxta-osseous soft-tissue sarcomas, where partial resection of the periosteum or bone was necessary for negative margin resection. 33 (14%) patients had complications. Mechanical failures included 4 (1.7%) structural host bone failures, 7 (2.9%) implant structural failures, and 1 (0.4%) aseptic loosening of distal locking screws. Nonmechanical failures included 8 (3.3%) peri-implant infections and 15 (6.3%) tumor progressions with implant contamination. The 90-day and 1-year mortalities were 28% (61/239) and 53% (53/102), respectively. The literature reported comparable failure and mortality rates with conventional titanium treatment.

Conclusions:

Carbon-fiber implants might be an alternative for treating impending and sustained pathological fractures secondary to metastatic bone disease. The seemingly comparable complication profile warrants further cohort studies comparing carbon-fiber and titanium nail complications.